Verrica Pharmaceuticals Inc. (VRCA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), powered by AI.

Current Price
$6.00
Sector
Healthcare
What is the Verrica Pharmaceuticals Inc. stock price forecast?

Verrica Pharmaceuticals Inc. is currently trading at $6.00. View real-time AI analysis on Alpha Lenz.

What is Verrica Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for Verrica Pharmaceuticals Inc. on Alpha Lenz.

What is Verrica Pharmaceuticals Inc.'s P/E ratio?

View Verrica Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.

Verrica Pharmaceuticals Inc.

NASDAQ · VRCA
$6.00+0.19(+3.27%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Verrica Pharmaceuticals Inc.'s future dividend policy...
Alpha Chat Insight

Verrica Pharmaceuticals Inc.'s ROE is -240.4%. Explore profitability and growth together.

Ask for details

Company Overview

Verrica Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative dermatological treatments, primarily for skin conditions with high unmet medical need. The company is known for its expertise in topical therapies, with a primary emphasis on non-systemic treatments that address prevalent skin diseases such as molluscum contagiosum and common warts. Verrica Pharmaceuticals operates in the healthcare and pharmaceuticals sector, where it leverages scientific research and clinical development to create solutions that improve the standard of care for both patients and healthcare professionals. The company's activities significantly impact the dermatology field, aiming to introduce new, effective therapies for conditions often underserved in the current market. With its commitment to advancing medical treatment options in dermatology, Verrica Pharmaceuticals plays a vital role in meeting patient needs and shaping innovation within this specialized industry.

CEODr. Jayson M. Rieger M.B.A., Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees71

Company Statistics

FY 2025

Profile

N/AMarket Cap
$35.58MRevenue
0.00Shares Out
71Employees

Margins

90.33%Gross
-28.76%EBITDA
-33.56%Operating
-50.27%Pre-Tax
-50.27%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

57.93%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-35.33%ROA
-240.35%ROE
-20.03%ROIC

Financial Health

$30.15MCash & Cash Equivalents
$-7.76MNet Debt
90.48%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Verrica Pharmaceuticals Inc. (ticker: VRCA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 71 employees.

The current price is $6 with a P/E ratio of -x and P/B of -x.

ROE is -240.35% and operating margin is -33.56%. Annual revenue is $36M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Verrica Pharmaceuticals Inc. (VRCA) Stock Forecast 2026 $6.00 — Price, Financials & Analyst Targets | Alpha Lenz